X0306 4 2022-03-16 0 0001652044 Alphabet Inc. GOOG 0001295231 Page Lawrence C/O ALPHABET INC. 1600 AMPHITHEATRE PKWY MOUNTAIN VIEW CA 94043 1 0 1 0 Class A Common Stock 2022-03-16 4 S 0 200 2637.035 D 6372 D Class A Common Stock 2022-03-16 4 S 0 100 2638.51 D 6272 D Class A Common Stock 2022-03-16 4 S 0 201 2639.7862 D 6071 D Class A Common Stock 2022-03-16 4 S 0 1085 2641.5347 D 4986 D Class A Common Stock 2022-03-16 4 S 0 744 2642.5046 D 4242 D Class A Common Stock 2022-03-16 4 S 0 800 2643.4113 D 3442 D Class A Common Stock 2022-03-16 4 S 0 188 2644.626 D 3254 D Class A Common Stock 2022-03-16 4 S 0 700 2645.7714 D 2554 D Class A Common Stock 2022-03-16 4 S 0 811 2646.9529 D 1743 D Class A Common Stock 2022-03-16 4 S 0 300 2648.0767 D 1443 D Class A Common Stock 2022-03-16 4 S 0 400 2649.49 D 1043 D Class A Common Stock 2022-03-16 4 S 0 200 2650.755 D 843 D Class A Common Stock 2022-03-16 4 S 0 300 2654.04 D 543 D Class A Common Stock 2022-03-16 4 S 0 68 2655.0953 D 475 D Class A Common Stock 2022-03-16 4 S 0 100 2657.16 D 375 D Class A Common Stock 2022-03-16 4 S 0 100 2658.66 D 275 D Class A Common Stock 2022-03-16 4 S 0 100 2659.99 D 175 D Class A Common Stock 2022-03-16 4 S 0 100 2662.49 D 75 D Class A Common Stock 2022-03-16 4 S 0 75 2665.97 D 0 D Class B Common Stock 0.00 Class A Common Stock 19522002 19522002 D Each share of Class A Common Stock was issued upon the conversion of one share of Class B Common Stock at the election of Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2,637.01 to $2,638.01, inclusive. The Reporting Person undertakes to provide to any security holder of Alphabet Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (14) to this Form 4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2,639.78 to $2,640.78, inclusive. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2,641 to $2,642, inclusive. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2,642.11 to $2,643.11, inclusive. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2,643.15 to $2,644.15, inclusive. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2,644.4 to $2,645.4, inclusive. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2,645.46 to $2,646.46, inclusive. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2,646.53 to $2,647.53, inclusive. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2,647.57 to $2,648.57, inclusive. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2,649.15 to $2,650.15, inclusive. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2,650.61 to $2,651.61, inclusive. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2,653.83 to $2,654.83, inclusive. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2,654.91 to $2,655.91, inclusive. All shares are exercisable as of the transaction date. There is no expiration date for the Issuer's Class B Common Stock. This Form 4 is fourth of four Form 4s filed on March 17, 2022 for transactions effected by the Reporting Person on March 16, 2022. All transactions were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person. /s/ Valentina Margulis as Attorney-in-Fact for Larry Page 2022-03-17